Cimzia (certolizumab) reduces the consequences of a substance within the body that may cause inflammation.
Cimzia is employed to treat the symptoms of regional enteritis when alternative medicine are tried while notsuccess.
Cimzia is additionally wont to treat moderate to severe autoimmune disease in adults.
Submit your review
Get emergency medical help if you have signs of an allergic reaction to Cimzia: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Serious and sometimes fatal infections may occur during treatment with Cimzia. Contact your doctor right away if you have signs of infection, such as: fever, chills, cough, sweating, muscle pain, open sores or skin wounds, unusual tiredness, feeling short of breath, painful urination, diarrhea, or weight loss.
Call your doctor right away if you have any of these symptoms of lymphoma:
chest pain, cough, feeling short of breath;
swelling in your neck, underarm, or groin (this swelling may come and go);
fever, night sweats, itching, weight loss, feeling tired;
feeling full after eating only a small amount; or
pain in your upper stomach that may spread to your back or shoulder.
Stop using Cimzia and call your doctor at once if you have:
shortness of breath (even with mild exertion);
swelling of your ankles or feet;
pale skin, easy bruising or bleeding;
nerve problems--vision problems, dizziness, numbness or tingly feeling, muscle weakness in your arms or legs;
liver problems--nausea, upper stomach pain, itching, tiredness, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes); or
lupus-like syndrome--joint pain or swelling, trouble breathing, or a butterfly-shaped skin rash over your cheeks and nose (worsens in sunlight).
Common Cimzia side effects may include:
pain or burning when you urinate;
cold symptoms such as stuffy nose, sneezing, sore throat.
Usual Adult Dose of Cimzia for Rheumatoid Arthritis: Initial dose: 400 mg subcutaneously (given as two subcutaneous injections of 200 mg) at weeks 0, 2, and 4, followed by 200 mg subcutaneously every other week Maintenance dose: 400 mg subcutaneously every 4 weeks in patients who obtain a clinical response Comments: -Injection sites should be rotated and injections should not be given in areas where the skin is tender, bruised, red, or hard. When a 400 mg dose is needed (given as 2 subcutaneous injections of 200 mg), injections should occur at separate sites in the thigh or abdomen. Use: For treatment of adults with moderately to severely active rheumatoid arthritis (RA)